top of page

Licensed Colombian medical cannabis platform targeting EU pharmaceutical market seeks $3M equity partner

Premium, fully licensed Colombian cannabis cultivation platform offering pharmaceutical-grade production at industry-leading costs, with secured European market access and scalable growth potential

Listing ID:

36324927098

Licence(s) Held:

Fully authorized Colombian entity for cultivation, processing, and international export of THC/CBD ; funding dedicated to scaling GACP certification and EU-GMP pathway compliance.

Seeking $3.0 Million for ~20% equity stake ($12M Pre-Money Valuation), dedicated to funding facility expansion, capacity scaling, and European market growth

Listing Details:

  • Colombian medical cannabis platform authorized for cultivation, processing, extraction, quality control, packaging, and international export of both THC and non-THC plants

  • Operations span 14 hoop houses (~30,000 sq ft) and greenhouses on ~80 acres of leased land in Colombia, at 9,000 ft elevation

  • Year-round cultivation with up to six harvests annually, producing premium flower at consistent 26–27% THC potency

  • Secured $4.88 million in confirmed in 2026 revenue across 6.5 tons of premium cannabis flower, with revenue projected to rise to $16.1M by 2030 (38% margin) as annual output scales to19 tonnes

  • Current government-approved cultivation capacity of 208,000 THC plants/year; total authorization recently increased to 500,000 plants (~5 tonnes)

  • Planned expansion adds 7,056 m² (75,974 sq ft) of greenhouse space supporting additional productions

  • Very low production costs, representing an 85–95% cost advantage versus Europe and Canada.

  • Holds exclusive partnerships with award-winning Emerald Triangle cultivators, serving as the regulated pathway to introduce their elite California genetics into the European medical cannabis market

  • Product portfolio includes premium THC flower (80%) and processing-focused activities (20%), along with proprietary CBD oils, cosmetics, body care, and white-label products

  • Established market access partnerships across Germany, Portugal, Poland, the U.K., Thailand, and the U.S., with a 5-year strategy to expand to 15+ European partners

  • Structured as a growth investment, enabling investors to access premium, cost-efficient European-focused cannabis production

36324927098

Inquiry Form

Thanks for submitting! We have received your message and will get back to you within 24 hours. Until then, you can send an email to info@hydeadvisory.com

Contact-us-deal

NEW CANNABIS BUSINESSES FOR SALE

See the latest cannabis business listings on the market including dispensaries, cultivation facilities, greenhouses, labs, and more. If you're looking to invest, acquire, or expand, these business opportunities provide the perfect starting point to grow your footprint in the cannabis industry.

Cannabis New/Featured Business Listing - Merger & Acquisition

36324927098

Licensed Colombian medical cannabis platform targeting EU pharmaceutical market seeks $3M equity partner

Cannabis New/Featured Business Listing - Merger & Acquisition

Premium, fully licensed Colombian cannabis cultivation platform offering pharmaceutical-grade production at industry-leading costs, with secured European market access and scalable growth potential

Cannabis New/Featured Business Listing - Merger & Acquisition

38939049737

4,800 sq ft licensed, micro-cultivation facility in AB for $500k

Cannabis New/Featured Business Listing - Merger & Acquisition

Opportunity to acquire a turnkey, fully built, turnkey 4,800 sq ft micro-cultivation facility in AB, offered at a significant discount to replacement cost

Cannabis New/Featured Business Listing - Merger & Acquisition

29345918591

State-of-the-art, ~130,000 sq. ft. production facility with 20.5 tonnes annual capacity and & EU-GMP designed processing hub

Cannabis New/Featured Business Listing - Merger & Acquisition

Opportunity to acquire a custom-designed, ~130,000 sq. ft. turnkey production asset including 84,000 square feet of canopy designed for pharmaceutical-grade output. This unique opportunity allows for a clean-slate acquisition of world-class infrastructure providing an immediate entry point into the global medicinal and premium international markets.

bottom of page